Topic: Health

A forgotten drug is being tested to treat a rare genetic disorder called Bachmann-Bupp syndrome. Early results are promising.

Researchers at Corewell Health and Michigan State University have found that a medication called difluoromethylornithine (DFMO) may help treat Bachmann-Bupp syndrome. This condition causes developmental challenges, including delays, low muscle tone, and hair loss. DFMO has been used to treat other conditions for decades.

The team at Every Cure is working with the researchers to strengthen the scientific evidence, increase awareness among doctors and rare disease groups, and support systems that ensure patients are properly identified and treated as research continues.

So far, a small number of patients have received DFMO through an FDA-approved protocol. The results are encouraging, but there are still challenges to overcome before this treatment can be widely available.

Despite the obstacles, the researchers remain hopeful. 'It's a hopeful and exciting time for all of us and more importantly, our patients,' said Caleb Bupp, M.D., pediatric geneticist for Corewell Health Helen DeVos Children's Hospital in Grand Rapids, Michigan.

Why It Matters

This breakthrough could bring new hope to Indian students who may have family members or friends affected by this rare disease. It also highlights the importance of collaboration and perseverance in medical research.

Key Facts

• Bachmann-Bupp syndrome is a rare genetic disorder that causes developmental challenges, including delays, low muscle tone, and hair loss.
• DFMO has been used to treat other conditions for decades, including West African sleeping sickness and neuroblastoma.
• The researchers are working with Every Cure to strengthen the scientific evidence and increase awareness among doctors and rare disease groups.
• A small number of patients have received DFMO through an FDA-approved protocol, with encouraging early results.

Key Terms

DFMO

A medication that has been used to treat other conditions for decades.

Implications

This breakthrough could bring new hope to Indian students who may have family members or friends affected by this rare disease. It also highlights the importance of collaboration and perseverance in medical research.